For the Inventor, By the Inventor

Enter assignee name

Vib Vzw

USPTO Granted Patents = 229

CIPO Patents = 28

EPO Patents = 148

Trademarks = 3

Forward Citations = 673

Loading Chart...

Loading Chart...

364 inventors (with patents filed for the assignee):

Jan Tavernier (42 out of 65 patents)

Jan Steyaert (18 out of 21 patents)

Els Pardon (17 out of 19 patents)

4. Toon Laeremans (15 out of 30 patents)

5. Gilles Uze (14 out of 15 patents)

6. Brian K Kobilka (13 out of 44 patents)

7. Frank Peelman (12 out of 13 patents)

8. Nikolai Kley (12 out of 25 patents)

9. Nico Callewaert (12 out of 13 patents)

10. Nico L M Callewaert (11 out of 15 patents)

11. Franciane Paul (10 out of 10 patents)

12. Wouter Vervecken (10 out of 18 patents)

13. Thierry Vandendriessche (10 out of 16 patents)

14. Pieter De Bleser (10 out of 10 patents)

15. Johan Thevelein (10 out of 10 patents)

Core Competencies:

CLEC9A Binding Agents

Single Molecule Peptide Sequencing

Nucleic Acid Regulatory Elements

Dendritic Cell Modulation

Fusokines

YAP/TAZ-TEAD Inhibition

Plant Growth Promotion

Recombinant Extracellular Vesicles

Chimeric Proteins

Tumor Hypoxia Markers

Opioid Receptor Binding Agents

Glycosylation Patterns

229 patents: Sort by Forward Citations

1. 12527843 - IMMUNE-CELL TARGETED BISPECIFIC CHIMERIC PROTEINS AND USES THEREOF (2026-01-20),

2. 12522641 - Targeted mutant interferon-gamma and uses thereof (2026-01-13),

3. 12521430 - METHODS OF GENERATING BROADLY PROTECTIVE VACCINE COMPOSITIONS COMPRISING NEURAMINIDASE (2026-01-13),

4. 12516361 - GENETICALLY ENGINEERED EUKARYOTIC CELLS PRODUCING SIALYLATED GLYCOPROTEINS (2026-01-06),

5. 12516064 - Tetrahydropyridopyrimidines and related analogs for inhibiting YAP/TAZ-TEAD (2026-01-06),

6. 12472254 - CD8+ T-CELLS LACKING PLEXINS AND THEIR APPLICATION IN CANCER TREATMENT (2025-11-18),

7. 12453770 - CLEC9A binding agents (2025-10-28),

8. 12422438 - Means and methods for single molecule peptide sequencing (2025-09-23),

9. 12419972 - Muscle-specific nucleic acid regulatory elements and methods and use thereof (2025-09-23),

10. 12410225 - Modulation of dendritic cell lineages (2025-09-09),

11. 12410222 - Fusokines involving cytokines with strongly reduced receptor binding affinities (2025-09-09),

12. 12409236 - Liver-specific nucleic acid regulatory elements and methods and use thereof (2025-09-09),

13. 12378202 - Tetrahydrobenzoazepinones and related analogs for inhibiting YAP/TAZ-TEAD (2025-08-05),

14. 12364753 - CD8 binding agents (2025-07-22),

15. 12285018 - Plant growth promoting microbial compositions (2025-04-29),

VIB (Flemish Institute for Biotechnology) is a non-profit research institute in Belgium. With more than 1,500 scientists, VIB conducts innovative research in life sciences, aiming to advance our understanding of biology and developing solutions for global challenges in the fields of agriculture, health, and industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

229 Patents

#2 in Ghent

#19 in Belgium

#3,634 in the World

Vib Vzw

Forward Citations = 673

364 inventors:

Jan Tavernier (42 out of 65 patents)

Jan Steyaert (18 out of 21 patents)

Els Pardon (17 out of 19 patents)

4. Toon Laeremans (15 out of 30 patents)

5. Gilles Uze (14 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…